🇺🇸 FDA
Pipeline program

Autologous Natural Killer Cell Therapy

22080996

Phase 1 small_molecule active

Quick answer

Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma is a Phase 1 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Hepatocellular Carcinoma
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials